4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-031917
Director bought 896,522 shares at an average $25.33 ($22,707,098)
- Director acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP Director | 2023-05-22 | Purchase | +7,645 | $24.46 | $187,000 | 3,529,258 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-22 | Purchase | +82,148 | $24.46 | $2,009,373 | 38,567,129 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-22 | Purchase | +3,781 | $24.80 | $93,769 | 3,533,039 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-22 | Purchase | +40,632 | $24.80 | $1,007,674 | 38,607,761 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-23 | Option exercise | +12,500 | $17.01 | $212,625 | 3,545,539 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-23 | Option exercise | +12,500 | $17.01 | $212,625 | 38,620,261 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-23 | Purchase | +10,858 | $25.33 | $275,035 | 3,556,397 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-23 | Purchase | +116,672 | $25.33 | $2,955,325 | 38,736,933 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-23 | Purchase | +6,941 | $25.54 | $177,273 | 3,563,338 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-23 | Purchase | +74,582 | $25.54 | $1,904,824 | 38,811,515 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-24 | Purchase | +20,304 | $25.27 | $513,129 | 3,583,642 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-24 | Purchase | +218,171 | $25.27 | $5,513,683 | 39,029,686 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-24 | Purchase | +2,688 | $25.51 | $68,581 | 3,586,330 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-24 | Purchase | +28,878 | $25.51 | $736,788 | 39,058,564 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-24 | Purchase | +24,113 | $25.65 | $618,498 | 3,610,443 | I |
| BAKER BROS. ADVISORS LP Director | 2023-05-24 | Purchase | +259,109 | $25.65 | $6,646,146 | 39,317,673 | I |
| Derivatives | |||||||
| BAKER BROS. ADVISORS LP Director | 2023-05-23 | Option exercise · Non-Qualified Stock Options (right to buy) | −12,500 | 0 | I | ||
| BAKER BROS. ADVISORS LP Director | 2023-05-23 | Option exercise · Non-Qualified Stock Options (right to buy) | −12,500 | 0 | I | ||
| Open-market purchases · 896,522 sh · avg $25.33 · $22,707,098 | |||||||
Loading xslF345X04/doc4.xml…